BZIP25 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300. Constituents: 50% Glycerol, 0.01M PBS, pH 7.4.
Form
Liquid
Lead Time
14-16 weeks lead time (made-to-order)
Synonyms
BZIP25 antibody; BZO2H4 antibody; At3g54620 antibody; T14E10.190 antibody; Basic leucine zipper 25 antibody; AtbZIP25 antibody; bZIP protein 25 antibody; Basic leucine zipper OPAQUE 2 homolog 4 antibody; Basic leucine zipper O2 homolog 4 antibody
Target Names
BZIP25
Uniprot No.

Target Background

Function
BZIP25 is a transcription factor that binds to the 5'-ACGT-3' core sequence, particularly within G-box-like motifs (e.g., 5'-CCACGTGGCC-3') and ABRE elements. It functions in the transcriptional activation of seed storage protein (SSP) encoding gene promoters (such as those for At2S and CRU3) in seeds. This activity is facilitated by its interaction with ABI3 and BZIP53.
Database Links

KEGG: ath:AT3G54620

STRING: 3702.AT3G54620.1

UniGene: At.1468

Protein Families
BZIP family
Subcellular Location
Nucleus.
Tissue Specificity
Expressed in roots, shoots, stems, leaves, stipulae, siliques, seeds, pollen, and flowers.

Q&A

What is the biological function of BZIP25 in Arabidopsis?

BZIP25 functions as a transcription factor belonging to the group C bZIPs in Arabidopsis thaliana. It regulates seed-specific gene expression, particularly of seed storage proteins (SSPs) and maturation (MAT) genes. Research demonstrates that BZIP25 physically interacts with ABI3 (a crucial transcriptional regulator in Arabidopsis seeds), which enhances in vitro DNA binding to SSP promoters and increases in vivo activation capacity . More recent studies have also identified BZIP25 as a regulator of epidermal cell development, where it is highly expressed in pavement cells (PCs) and early-stage meristemoid cells .

What is the recommended protocol for using BZIP25 antibody in plant samples?

For optimal results with BZIP25 antibody:

  • Sample Preparation: Grind plant tissue in liquid nitrogen and extract proteins using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, and protease inhibitors.

  • Western Blotting: Use 10-20 μg of total protein per lane. After transfer to a membrane, block with 5% non-fat milk in TBST for 1 hour at room temperature.

  • Antibody Incubation: Dilute primary BZIP25 antibody (such as CSB-PA881893XA01DOA) at 1:1000 in blocking solution and incubate overnight at 4°C .

  • Detection: After washing, incubate with HRP-conjugated secondary antibody and develop using chemiluminescence.

  • Storage: Store the lyophilized antibody according to manufacturer recommendations, typically at -20°C. Avoid repeated freeze-thaw cycles to maintain antibody activity .

How can I verify the specificity of BZIP25 antibody in my experiments?

To verify BZIP25 antibody specificity:

  • Positive and Negative Controls: Always include wild-type samples (positive control) alongside bzip25 mutant samples (negative control) when performing immunoblotting.

  • Peptide Competition Assay: Pre-incubate your antibody with the immunizing peptide before applying to your samples. A specific antibody signal should be significantly reduced or eliminated.

  • Cross-Reactivity Testing: Test the antibody against recombinant proteins of closely related bZIPs (particularly bZIP10, which shares high sequence homology).

  • Comparative Analysis: Compare results using different antibody preparations or epitopes against BZIP25 to confirm consistent detection patterns.

  • Multiple Detection Methods: Validate antibody specificity using both Western blot and immunohistochemistry or immunofluorescence to ensure consistent localization patterns .

What are the best experimental approaches to study BZIP25-mediated gene regulation?

To comprehensively investigate BZIP25-mediated gene regulation:

  • Chromatin Immunoprecipitation (ChIP): Using BZIP25 antibody, perform ChIP followed by qPCR or sequencing to identify direct binding targets. This approach successfully identified direct binding of related bZIP53 to promoters like the 2S2 promoter .

  • Transient Expression Assays: Utilize Arabidopsis leaf protoplasts or particle bombardment with reporter constructs containing putative BZIP25 target promoters (like SSP promoters) fused to reporters such as GUS or luciferase .

  • Protein-DNA Binding Assays: Implement in vitro DNA binding assays such as EMSA or DNA-protein binding ELISA to study the interaction of BZIP25 with specific DNA sequences. This approach revealed that bZIP heterodimers with bZIP53 significantly enhanced DNA binding compared to individual bZIPs .

  • Bimolecular Fluorescence Complementation (BiFC): Use BiFC coupled with flow cytometric analysis to study BZIP25 heterodimerization patterns in vivo .

  • Transcriptomics in Gain/Loss-of-Function Lines: Compare gene expression profiles in wild-type, bzip25 mutant, and BZIP25 overexpression lines to identify differentially regulated genes .

How does BZIP25 form protein complexes, and with which partners?

BZIP25 forms complex interaction networks primarily through its leucine zipper domain:

  • Heterodimer Formation: BZIP25 preferentially forms heterodimers with group S1 bZIPs, particularly bZIP53. These heterodimers show significantly enhanced DNA binding activity compared to individual bZIPs .

  • Enhanceosome Formation: BZIP25 participates in higher-order complexes or "enhanceosomes." Research shows that BZIP25 physically interacts with the seed-specific transcriptional regulator ABI3, forming ternary complexes with bZIP heterodimers that dramatically increase target gene transcription .

  • Network Specificity: Interaction studies reveal that BZIP25 operates within a specific bZIP interaction network. According to BiFC analysis coupled with flow cytometry, the 16 Arabidopsis bZIPs studied interact in three isolated networks, with BZIP25 belonging to a network showing non-specific dimerization within its members .

  • Structural Basis: The specificity and dynamics of these interactions are explained by differences in the length, structure, and composition of their leucine zippers, which correlate well with the observed in vivo dimerization patterns .

What experimental evidence supports the role of BZIP25 in epidermal cell development?

Recent research has revealed BZIP25's unexpected role in epidermal cell development:

  • Single-Cell RNA Sequencing: Transcriptional profiling of epidermal cells in 3-day-old true leaves of Arabidopsis identified BZIP25 and BZIP53 as highly expressed in pavement cells (PCs) and early-stage meristemoid cells .

  • Mutant Analysis: In bzip25 and bzip53 mutants, researchers observed increased density of pavement cells and decreased density of trichome cells compared to wild-type plants .

  • Phytohormone Response: The phenotypic differences between mutants and wild-type plants became more pronounced in the presence of jasmonic acid (JA), suggesting that these transcription factors regulate trichome and pavement cell development in response to JA signaling .

  • Cell Fate Determination: The data indicate that BZIP25 plays a role in the fate determination between different epidermal cell types, specifically in the balance between pavement cells and trichomes .

How do the DNA binding specificities of BZIP25 heterodimers differ from those of BZIP25 homodimers?

The DNA binding specificities of BZIP25 show critical differences between heterodimeric and homodimeric states:

  • Homodimeric Binding: BZIP25 alone shows limited DNA binding capacity. DAP-seq experiments found no significant binding site enrichment for any Group C members (including BZIP25) when tested alone, despite having a highly conserved bZIP DNA-binding domain .

  • Heterodimeric Binding Enhancement: When BZIP25 forms heterodimers with compatible S1 group bZIPs, DNA binding activity is dramatically enhanced. This is demonstrated by reporter gene assays where cotransformation of BZIP25 with BZIP53 produced a significant increase in reporter activity compared to individual bZIPs .

  • Novel Binding Motifs: Heterodimer formation can lead to recognition of novel DNA binding motifs. While individual bZIPs typically recognize G-box, C-box, or ACT motifs (ACTCAT), heterodimers may target unique sequences not recognized by either homodimer .

  • Binding Site Selection: The heterodimer composition influences binding site preference, with different heterodimer pairs showing distinct binding patterns across the genome. This suggests a combinatorial mechanism where specific dimers target unique genomic regions .

What mechanisms regulate BZIP25 activity during plant development and stress responses?

BZIP25 activity is regulated through multiple mechanisms:

  • Transcriptional Regulation: Unlike BZIP1 and BZIP53, which show strong transcriptional induction during dark-induced starvation, BZIP25's expression pattern appears to be more constitutive, suggesting distinct transcriptional regulation mechanisms .

  • Posttranslational Modifications: Protein stability may be regulated through mechanisms similar to those observed with other bZIPs. For instance, coexpression of BZIP10 and BZIP53 leads to enhanced protein levels, suggesting that heterodimer formation might stabilize bZIP proteins from degradation .

  • Partner Availability: The activity of BZIP25 is highly dependent on the availability of dimerization partners. The ratio of different bZIP heterodimers strongly correlates with the level of target gene activation .

  • Energy Signaling Integration: Given the role of related bZIPs in energy starvation responses, BZIP25 likely integrates energy status signals, potentially through interaction with other bZIPs that are transcriptionally and posttranscriptionally activated during energy stress .

  • Developmental Programming: BZIP25's dual roles in seed development and epidermal cell fate determination suggest tissue-specific regulation mechanisms that respond to developmental cues .

How does the leucine zipper structure of BZIP25 contribute to its dimerization specificity?

The leucine zipper structure of BZIP25 is critical for its dimerization specificity:

  • Structural Determinants: In silico analysis of the leucine zipper domain reveals specific differences in length, structure, and amino acid composition that explain dimerization specificity and in vivo dynamics .

  • Dimerization Networks: The 16 Arabidopsis bZIPs studied interact in three isolated networks, within which members dimerize non-specifically and exhibit functional redundancy. BZIP25's leucine zipper structure places it within a specific network that determines its potential dimerization partners .

  • Electrostatic Interactions: The leucine zipper contains a pattern of charged residues that forms a characteristic electrostatic surface, creating attraction or repulsion between potential dimerization partners. These interactions help explain why BZIP25 forms strong heterodimers with some S1 bZIPs but not others .

  • Evolutionary Conservation: The structural features determining BZIP25's dimerization specificity are evolutionarily conserved, suggesting their fundamental importance to bZIP function across plant species .

What are the key considerations when designing experiments to investigate BZIP25 and BZIP53 co-regulation of target genes?

When investigating co-regulation by BZIP25 and BZIP53:

  • Genetic Redundancy: Consider the functional redundancy within bZIP networks. Single mutant analysis may not show clear phenotypes due to compensation by other bZIPs. Design experiments using double or higher-order mutants (e.g., bzip25 bzip53 double mutants) .

  • Heterodimer-Specific Effects: To distinguish between BZIP25 homodimer and BZIP25-BZIP53 heterodimer effects, use artificial tethered dimers where BZIP25 and BZIP53 are linked by a flexible linker to ensure exclusive heterodimer formation .

  • Developmental Timing: Consider temporal regulation, as bZIP expression and activity vary during development. For seed development studies, analyze multiple developmental stages; for epidermal cell studies, focus on early leaf development (e.g., 3-day-old true leaves) .

  • Environmental Conditions: Include treatments that trigger relevant responses, such as energy starvation (extended darkness) or jasmonic acid application, which enhance phenotypic differences between wild-type and mutant plants .

  • Tissue-Specific Analysis: Employ techniques like cell-type-specific transcriptomics or translatomics to distinguish effects in different tissues, especially when studying processes like epidermal cell differentiation .

What approaches can overcome the challenges of studying weakly interacting bZIP partners with BZIP25?

For studying weak or transient BZIP25 interactions:

  • Enhanced BiFC Systems: Use split fluorescent proteins with increased sensitivity or faster maturation times to detect weak or transient interactions. Quantitative flow cytometric analysis can provide objective measurement of interaction strengths .

  • Crosslinking Approaches: Employ in vivo crosslinking prior to immunoprecipitation to capture transient interactions. This can be particularly useful for interactions that may be biologically relevant despite their weak nature.

  • Artificial Concentration Systems: Utilize systems that increase local concentration of interaction partners, such as membrane recruitment or nuclear tethering, to enhance detection of weak interactions.

  • In Vitro Validation: Complement in vivo approaches with in vitro methods like surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) to quantitatively measure interaction affinities.

  • Modified Expression Conditions: Test interactions under different conditions that might stabilize weak interactions, such as during specific stress responses or developmental stages when cofactors might be present .

How can researchers accurately distinguish between direct and indirect effects of BZIP25 on gene expression?

To distinguish direct from indirect BZIP25 regulatory effects:

  • Chromatin Immunoprecipitation: Perform ChIP-seq with BZIP25 antibody to identify genome-wide binding sites. Compare with transcriptome data to identify genes that are both bound and regulated .

  • DAP-seq and dDAP-seq: Utilize DNA affinity purification sequencing for both BZIP25 alone and in combination with potential heterodimer partners to comprehensively map binding sites and compare with gene expression changes .

  • Inducible Systems: Employ systems allowing rapid induction of BZIP25 activity (e.g., glucocorticoid-inducible expression) combined with translational inhibitors like cycloheximide to identify primary response genes that change expression without requiring new protein synthesis.

  • Binding Site Mutations: Validate direct regulation by introducing mutations in putative BZIP25 binding sites in target promoters and testing the effect on expression in reporter assays or using CRISPR-based approaches in the native genomic context .

  • Temporal Resolution: Perform high-resolution time-course experiments after BZIP25 induction to distinguish between early (likely direct) and late (potentially indirect) gene expression changes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.